Tonix Pharmaceuticals Holding Corp (TNXP)
SG&A Expenses
$99.22M
TTM · Period ending: · USD
TNXP SG&A Expenses
Latest reported$99.22Mperiod ending
Latest reported$99.22Mperiod ending
TNXP TTM SG&A Expenses ($14.02K → $99.22M)
TTM SG&A Expenses
High-resolution chart · PNG
TNXP sg&a expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 99,217,000 | |
| 63,258,000 | |
| 45,293,000 | |
| 25,686,000 | |
| 25,686,000 | |
| 33,188,000 | |
| 32,394,000 | |
| 26,942,000 | |
| 35,654,000 | |
| 35,178,000 | |
| 33,259,000 | |
| 31,183,000 | |
| 29,861,000 | |
| 29,592,000 | |
| 30,215,000 | |
| 29,344,000 | |
| 27,407,000 | |
| 26,079,000 | |
| 23,474,000 | |
| 21,217,000 | |
| 18,950,000 | |
| 17,142,000 | |
| 14,354,000 | |
| 12,472,000 | |
| 12,125,000 | |
| 10,856,000 | |
| 10,636,000 | |
| 10,185,000 | |
| 9,623,000 | |
| 9,347,000 | |
| 8,764,000 | |
| 8,080,000 | |
| 7,730,000 | |
| 7,670,000 | |
| 7,949,000 | |
| 8,671,000 | |
| 8,887,000 | |
| 9,191,000 | |
| 10,437,000 | |
| 11,718,000 | |
| 12,541,000 | |
| 13,134,000 | |
| 12,658,000 | |
| 11,975,000 | |
| 11,226,000 | |
| 10,287,000 | |
| 9,039,000 | |
| 8,192,000 | |
| 7,429,853 | |
| 6,597,547 | |
| 6,239,143 | |
| 5,073,159 | |
| 4,694,505 | |
| 4,575,961 | |
| 4,078,102 | |
| 5,073,094 | |
| 3,999,217 | |
| 2,977,583 | |
| 2,220,361 | |
| 11,168 | |
| 12,531 | |
| 13,417 | |
| 13,724 | |
| 15,391 | |
| 14,319 | |
| 17,325 | |
| 13,867 | |
| 19,362 | |
| 19,161 | |
| 16,342 | |
| 14,023 |